The FEATHER ( FEbuxostat versus placebo rAndomized controlled Trial regarding reduced renal function in patients with Hyperuricemia complicated by chRonic kidney disease stage 3 ) study is a prospective , multicenter , double-blind , randomized , placebo-controlled trial of febuxostat-a novel , nonpurine , selective , xanthine oxidase inhibitor .